Cash & equivalents increased 209.7%
Cash & equivalents changed +209.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +209.7% from the comparable as-filed period.
Inventory changed +87.4% from the comparable as-filed period.
Net income changed +31.3% from the comparable as-filed period.
Operating income changed +42.3% from the comparable as-filed period.
Operating margin changed +12776 basis points from the comparable as-filed period.
Revenue changed +91.8% from the comparable as-filed period.
Debt changed +5.9% from the comparable as-filed period.
Research & development changed +9.3% from the comparable as-filed period.
Stock-based compensation changed +1.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.